Hippeastrum reticulatum (Amaryllidaceae): Alkaloid Profiling, Biological Activities and Molecular Docking.

about

Hippeastrum reticulatum (Amaryllidaceae): Alkaloid Profiling, Biological Activities and Molecular Docking.

Item

http://www.wikidata.org/entity/Q47302195

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Hippeastrum reticulatum (Amary ...... ivities and Molecular Docking.

@en

Hippeastrum reticulatum (Amary ...... ivities and Molecular Docking.

@nl

type

Item

label

Hippeastrum reticulatum (Amary ...... ivities and Molecular Docking.

@en

Hippeastrum reticulatum (Amary ...... ivities and Molecular Docking.

@nl

prefLabel

Hippeastrum reticulatum (Amary ...... ivities and Molecular Docking.

@en

Hippeastrum reticulatum (Amary ...... ivities and Molecular Docking.

@nl

P1476

Hippeastrum reticulatum (Amary ...... tivities and Molecular Docking

@en

P2093

Vanessa Dias Dos Santos

http://www.w3.org/2001/XMLSchema#string

P2860

A subfamilial classification for the expanded asparagalean families Amaryllidaceae, Asparagaceae and Xanthorrhoeaceae

Alzheimer's Disease

A new and rapid colorimetric determination of acetylcholinesterase activity

Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution

Structures of human acetylcholinesterase in complex with pharmacologically important ligands

Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

Strategies for discovering drugs from previously unexplored natural products.

Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries.

Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease.

P31

scholarly article

P356

10.3390/MOLECULES22122191

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Warley de Souza Borges

Luciana R Tallini

José Angelo S Zuanazzi

P577

2017-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29232852

http://www.w3.org/2001/XMLSchema#string

P932

6149799

http://www.w3.org/2001/XMLSchema#string